Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Companies Breaking news SAGE Therapeutics Inc
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Juniper Networks Inc Breaking News: Markets Economy
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags Finance Progressive Corp Biogen Inc
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags US: News Business News Wells Fargo & Co
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Politics Markets Citigroup Inc
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags US: News Eli Lilly and Co Health & Science
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Health care industry Business Biogen Inc
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Pharmaceuticals Law and Regulation Health & Science
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags Rivian Automotive Inc TG Therapeutics Inc Biogen Inc
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Costco Wholesale Corp stocks Market Insider
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags World Markets Biogen Inc Pharmaceuticals
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags US: News Social issues Health & Science
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Finance Steel Dynamics Inc Biogen Inc
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Biotechnology Epidemics Biotech and Pharmaceuticals
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Policy Health & Science U/S/ Economy
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Oil and Gas Investment Strategy Biogen Inc
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Biogen Inc Business Health care industry
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Chegg Inc Finance Generac Holdings Inc
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Policy Disease outbreaks Health & Science
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Quest Diagnostics Inc CVS Health Corp Eli Lilly and Co
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Disease outbreaks Policy Health & Science
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Eli Lilly and Co US: News Health & Science
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Companies Breaking news Medication
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Eisai Co Ltd Science Breaking News: Business
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Eli Lilly and Co US: News Pharmaceuticals
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Breaking News: Business US: News Biotechnology
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Disease outbreaks Policy Health & Science
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Coronavirus Biotech and Pharmaceuticals Epidemics
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags Epidemics Biotechnology Coronavirus
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.